CRADL NERVE CAP Trademark

Trademark Overview

On Thursday, March 2, 2023, a trademark application was filed for CRADL NERVE CAP with the United States Patent and Trademark Office. The USPTO has given the CRADL NERVE CAP trademark a serial number of 97820673. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 14, 2025. This trademark is owned by Tulavi Therapeutics, Inc.. The CRADL NERVE CAP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, hydrogel for medical purposes
cradl nerve cap

General Information

Serial Number97820673
Word MarkCRADL NERVE CAP
Filing DateThursday, March 2, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements

Goods and ServicesPharmaceuticals, namely, hydrogel for medical purposes
NOT AVAILABLE"NERVE CAP"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTulavi Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Gatos, CA 95032
Party NameTulavi Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Gatos, CA 95032

Trademark Events

Event DateEvent Description
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023NEW APPLICATION ENTERED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Friday, March 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, February 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 14, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, July 14, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, November 19, 2024SOU EXTENSION 1 FILED
Friday, February 21, 2025SOU EXTENSION 1 GRANTED
Tuesday, November 19, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

nerve cradl purposes medical hydrogel namely pharmaceuticals